[go: up one dir, main page]

GB2162061B - Controlled time release therapeutic composition having means for counteracting overdosage - Google Patents

Controlled time release therapeutic composition having means for counteracting overdosage

Info

Publication number
GB2162061B
GB2162061B GB08411355A GB8411355A GB2162061B GB 2162061 B GB2162061 B GB 2162061B GB 08411355 A GB08411355 A GB 08411355A GB 8411355 A GB8411355 A GB 8411355A GB 2162061 B GB2162061 B GB 2162061B
Authority
GB
United Kingdom
Prior art keywords
overdosage
counteracting
therapeutic composition
time release
controlled time
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08411355A
Other versions
GB8411355D0 (en
GB2162061A (en
Inventor
Bibhuti B Bardhan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB08411355A priority Critical patent/GB2162061B/en
Publication of GB8411355D0 publication Critical patent/GB8411355D0/en
Publication of GB2162061A publication Critical patent/GB2162061A/en
Application granted granted Critical
Publication of GB2162061B publication Critical patent/GB2162061B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
GB08411355A 1984-05-03 1984-05-03 Controlled time release therapeutic composition having means for counteracting overdosage Expired GB2162061B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08411355A GB2162061B (en) 1984-05-03 1984-05-03 Controlled time release therapeutic composition having means for counteracting overdosage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08411355A GB2162061B (en) 1984-05-03 1984-05-03 Controlled time release therapeutic composition having means for counteracting overdosage

Publications (3)

Publication Number Publication Date
GB8411355D0 GB8411355D0 (en) 1984-06-06
GB2162061A GB2162061A (en) 1986-01-29
GB2162061B true GB2162061B (en) 1988-11-16

Family

ID=10560447

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08411355A Expired GB2162061B (en) 1984-05-03 1984-05-03 Controlled time release therapeutic composition having means for counteracting overdosage

Country Status (1)

Country Link
GB (1) GB2162061B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524515B2 (en) 2003-01-10 2009-04-28 Mutual Pharmaceuticals, Inc. Pharmaceutical safety dosage forms
ES2653568T3 (en) 2004-06-12 2018-02-07 Collegium Pharmaceutical, Inc. Drug formulations for abuse prevention
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
DK2915525T3 (en) 2011-09-19 2021-08-23 Orexo Ab Sublingual abuse-resistant tablets comprising buprenorphine and naloxone
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
US20210220329A1 (en) * 2018-02-08 2021-07-22 The United State of America, as represented by the Secretary, Department of Health and Human Service A method of treating triple-negative breast cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617488A1 (en) * 1965-03-29 1971-03-18 Gibson William Carleton Process for the production of pharmaceuticals, stimulants and luxury foods
GB1428361A (en) * 1972-02-15 1976-03-17 Grant A Safeguarded medicinal compositions
US4175119A (en) * 1978-01-11 1979-11-20 Porter Garry L Composition and method to prevent accidental and intentional overdosage with psychoactive drugs

Also Published As

Publication number Publication date
GB8411355D0 (en) 1984-06-06
GB2162061A (en) 1986-01-29

Similar Documents

Publication Publication Date Title
GB2207353B (en) Controlled release formulation
IL80643A0 (en) Controlled release pharmaceutical compositions
EP0251459A3 (en) Controlled release pharmaceutical composition
EP0306236A3 (en) Controlled release formulations
EP0184910A3 (en) Device for controlled release drug delivery
IL92662A0 (en) Composition for controlled release of polypeptides
EP0277799A3 (en) Digitally controlled positioning system
GB2122490B (en) Controlled release formulation
PH20391A (en) Controlled release pharmaceutical preparations
GB8530331D0 (en) Release means
GB2162061B (en) Controlled time release therapeutic composition having means for counteracting overdosage
GB8514030D0 (en) Controlled release iodine
GB2135579B (en) Controlled release fungicidal formulation
ZA882627B (en) Setting composition
GB8521221D0 (en) Controlled release formulations
YU64888A (en) Two-microprocessors controlling system
IL74459A (en) Controlled release pharmaceutical compositions containing bromocriptine
ZA86705B (en) Controlled release insecticide
GB2163419B (en) Controlled release nutrients
ZA893966B (en) Controlled release composition
GB2175503B (en) Controlled release herbicidal composition
EG17797A (en) Controlled release formulation
IE840461L (en) Controlled release formulation comprising a¹triazolobenzothiazole
IE871371L (en) Compositions for transdermal therapeutic systems of¹diuretics
IE863030L (en) Controlled release composition

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee